Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 1
1999 1
2001 4
2002 1
2003 4
2004 3
2005 7
2006 6
2007 11
2008 7
2009 11
2010 7
2011 8
2012 7
2013 6
2014 5
2015 3
2016 6
2017 2
2019 2
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, Mannel RS, Kim JW, Salani R, DiSilvestro PA, Burke JJ, Rutherford T, Spirtos NM, Terada K, Anderson PR, Brewster WR, Small W, Aghajanian CA, Miller DS. Randall ME, et al. Among authors: mcmeekin ds. J Clin Oncol. 2019 Jul 20;37(21):1810-1818. doi: 10.1200/JCO.18.01575. Epub 2019 Apr 17. J Clin Oncol. 2019. PMID: 30995174 Free PMC article. Clinical Trial.
Where is the future of endometrial cancer therapy?
McMeekin DS. McMeekin DS. Ann Oncol. 2009 Nov;20(11):1757-61. doi: 10.1093/annonc/mdp493. Ann Oncol. 2009. PMID: 19861581 Free article. Review. No abstract available.
Role of pegylated liposomal doxorubicin in ovarian cancer.
Thigpen JT, Aghajanian CA, Alberts DS, Campos SM, Gordon AN, Markman M, McMeekin DS, Monk BJ, Rose PG. Thigpen JT, et al. Among authors: mcmeekin ds. Gynecol Oncol. 2005 Jan;96(1):10-8. doi: 10.1016/j.ygyno.2004.09.046. Gynecol Oncol. 2005. PMID: 15589573 Review.
Targeted therapies for gynecologic malignancies.
Hyde J, McMeekin DS. Hyde J, et al. Among authors: mcmeekin ds. Curr Treat Options Oncol. 2005 Mar;6(2):121-32. doi: 10.1007/s11864-005-0020-3. Curr Treat Options Oncol. 2005. PMID: 15717994 Review.
Consolidation therapy in ovarian cancer: where do we stand?
Dearnley DD, McMeekin DS. Dearnley DD, et al. Among authors: mcmeekin ds. Curr Opin Obstet Gynecol. 2006 Feb;18(1):3-7. doi: 10.1097/01.gco.0000192995.20040.ff. Curr Opin Obstet Gynecol. 2006. PMID: 16493252 Review.
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA. Brasky TM, et al. Among authors: mcmeekin ds. J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251. J Natl Cancer Inst. 2017. PMID: 28376204 Free PMC article.
90 results